Case number 1:22-cv-00966
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 18, 2025 | 161 | STIPULATION TO EXTEND TIME for the parties to request redaction of the May 20, 2025 transcript to June 25, 2025 - filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) (Entered: 06/18/2025) (2) |
| Jun 5, 2025 | 159 | NOTICE OF SERVICE of (1) Opening Expert Report of Robert Giusti, MD Regarding Infringement, (2) Opening Expert Report of Gregory Sawicki, MD, MPH Regarding Infringement, (3) Opening Expert Report of Cory J. Berkland, Ph.D. Regarding Infringement and (4) Opening Expert Report of Robert K. Prud'homme, Ph.D. Regarding Infringement - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 06/05/2025) (3) |
| Jun 5, 2025 | 160 | NOTICE OF SERVICE regarding Lupin Limited and Lupin Pharmaceuticals, Inc.s Opening Expert Report of Umesh V. Banakar, PhD and Opening Expert Report of Dr. Kelly Smith, MD, filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) Modified on 6/6/2025 (nms). (Entered: 06/05/2025) (2) |
| May 30, 2025 | 158 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.s Second Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporateds Second Set of Interrogatories (Nos. 7-21) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) (Entered: 05/30/2025) (2) |
| May 28, 2025 | 156 | Official Transcript of Discovery Conference held on 5/20/25 before Judge Richard Andrews. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 6/18/2025. Redacted Transcript Deadline set for 6/30/2025. Release of Transcript Restriction set for 8/26/2025. (Warner, Deanna) (Entered: 05/28/2025) (0) |
| May 28, 2025 | 157 | REDACTED VERSION of 145 Letter, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Proposed Order)(Murphy, Francis) Modified on 5/28/2025 (nms). (Entered: 05/28/2025) (0) |
| May 23, 2025 | 152 | NOTICE of Withdrawal of Counsel by Vertex Pharmaceuticals Incorporated (Dellinger, Megan) (Entered: 05/23/2025) (2) |
| May 23, 2025 | 154 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Third Supplemental Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Interrogatories (Nos. 1, 2, and 3) - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 05/23/2025) (3) |
| May 23, 2025 | 155 | ANSWER to Complaint and Counterclaims of Defendant Lupin Limited (see Complaint in C.A. 25-450-RGA) by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) Modified on 5/23/2025 (nms). (Entered: 05/23/2025) (17) |
| May 21, 2025 | 151 | ORAL ORDER: The redacted filing (D.I. 150 ) is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document, or parts of it, that contains publicly available materials is prima facie evidence of bad faith. A revised redacted filing is DUE within five business days. Ordered by Judge Richard G. Andrews on 5/21/2025. (nms) (Entered: 05/21/2025) (0) |
| May 20, 2025 | 150 | REDACTED VERSION of 145 Letter, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Proposed Order)(Murphy, Francis) Modified on 5/20/2025 (nms). (Entered: 05/20/2025) (0) |
| May 16, 2025 | 146 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Fourth Amended Initial Disclosures Under Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 05/16/2025) (3) |
| May 16, 2025 | 147 | REDACTED VERSION of 137 Notice to Take Deposition - by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) (Entered: 05/16/2025) (5) |
| May 16, 2025 | 148 | NOTICE OF SERVICE of (1) Lupin Limited and Lupin Pharmaceuticals, Inc.s Second Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporateds Second Set of Interrrogatories; (2) Lupin Limited and Lupin Pharmaceuticals, Inc.s Fourth Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporateds First Set of Interrogatories (NOS. 1-6); (3) Lupin Limited and Lupin Pharmaceuticals, Incs Third Amended Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures; (4) Lupin Limited and Lupin Pharmaceuticals, Incs Third Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard For Discovery; and (5) Lupin Limited and Lupin Pharmaceuticals, Incs Initial Invalidity Contentions with Respect to U.S. Patent No. 12,214,083, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 5/19/2025 (nms). (Entered: 05/16/2025) (0) |
| May 16, 2025 | 149 | REDACTED VERSION of 144 Letter, by Vertex Pharmaceuticals Incorporated. (Attachments: # 1 Exhibits 1-5, # 2 Proposed Order)(Fahnestock, Derek) Modified on 5/19/2025 (nms). (Entered: 05/16/2025) (0) |
| May 13, 2025 | 145 | [SEALED] Letter to The Honorable Richard G. Andrews, from Francis J. Murphy, Esq., regarding opposition to motion to compel interrogatory responses pursuant to Fed. C. P. 26 and 33. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Proposed Order)(Murphy, Francis) Modified on 5/13/2025 (nms). (Entered: 05/13/2025) (0) |
| May 9, 2025 | 143 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Vertex Pharmaceuticals Incorporated's Supplemental Notice of Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. Pursuant to FED. R. CIV. P. 30(b)(6), filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 5/12/2025 (nms). (Entered: 05/09/2025) (0) |
| May 9, 2025 | 144 | [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding motion to compel interrogatory responses pursuant to Fed. R. Civ. P. 26 and 33. (Attachments: # 1 Exhibits 1-5, # 2 Proposed Order)(Fahnestock, Derek) Modified on 5/11/2025 (nms). (Entered: 05/09/2025) (0) |
| May 6, 2025 | 142 | ORAL ORDER: The parties have advised that a dispute has arisen requiring attention. The Court will hold a discovery conference on 5/20/2025, at 2:00 PM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 5/6/2025. (nms) (Entered: 05/06/2025) (0) |
| May 5, 2025 | 141 | SO ORDERED Granting (D.I. 11 in 25-cv-450-RGA; D.I. 140 in 22-cv-966-RGA) Joint Stipulation to Consolidate. Signed by Judge Richard G. Andrews on 5/5/2025. Associated Cases: 1:22-cv-00966-RGA, 1:25-cv-00450-RGA(nms) (Entered: 05/05/2025) (3) |
| May 2, 2025 | 139 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Initial Disclosures Under Paragraph 4(c) of the District of Delaware Default Standard for Discovery with Respect to U.S. Patent No. 12,214,083 - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 05/02/2025) (3) |
| May 2, 2025 | 140 | JOINT Stipulation to Consolidate, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 5/4/2025 (nms). (Entered: 05/02/2025) (3) |
| Apr 23, 2025 | 138 | NOTICE of Change of Address, by Francis J. Murphy, Jr. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 4/23/2025 (nms). (Entered: 04/23/2025) (0) |
| Apr 18, 2025 | 137 | [SEALED] Supplemental Notice to Take Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. on May 8, 2025, filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) Modified on 4/18/2025 (nms). Modified on 4/21/2025 (aas). (Entered: 04/18/2025) (0) |
| Apr 11, 2025 | 136 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Initial Disclosures Under Paragraph 4(a) of the District of Delaware Default Standard for Discovery with Respect to U.S. Patent No. 12,214,083 - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 04/11/2025) (3) |
| Apr 4, 2025 | 135 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc's Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's Third Set of Interrogatories (NOS. 22-23); and Lupin Limited and Lupin Pharmaceuticals, Inc.'s Third Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's First Set of Interrogatories (NOS. 1-6) filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service Certificate of Service)(Murphy, Francis) (Entered: 04/04/2025) (0) |
| Mar 25, 2025 | 133 | Joint Stipulation to Amend Scheduling Order, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 3/25/2025 (nms). (Entered: 03/25/2025) (4) |
| Mar 25, 2025 | 134 | SO ORDERED Granting 133 Joint Stipulation to Amend Scheduling Order (*Reset Deadlines/Hearings: A Final Pretrial Conference is now set for 1/23/2026, at 9:00 AM in Courtroom 6A. A 3-day Bench Trial is set to begin on 2/2/2026, at 8:30 AM in Courtroom 6A). Signed by Judge Richard G. Andrews on 3/25/2025. (aas) Modified on 3/25/2025 (nms). (Entered: 03/25/2025) (4) |
| Mar 17, 2025 | 132 | ORAL ORDER: The parties have advised they have reached agreement on the impasse that is scheduled to be heard on March 26, 2025. In light of that resolution the hearing scheduled for March 26, 2025, is CANCELED. Ordered by Judge Richard G. Andrews on 3/17/2025. (nms) (Entered: 03/17/2025) (0) |
| Mar 3, 2025 | 131 | ORAL ORDER: The parties have advised that a dispute has arisen requiring attention. The Court will hold a discovery conference on 3/26/2025, at 3:00 PM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 3/3/2025. (nms) (Entered: 03/03/2025) (0) |
| Feb 28, 2025 | 129 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc's First Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's First Set of Requests for Admission (NOS.1-3); Lupin Limited and Lupin Pharmaceuticals, Inc.'s Second Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's First Set of Requests for Interrogatories (NOS.1-6) and Lupin Limited and Lupin Pharmaceuticals, Inc's First Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's Second Set of Interrogatories (NOS.7-21) filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 3/3/2025 (nms). (Entered: 02/28/2025) (0) |
| Feb 28, 2025 | 130 | NOTICE OF SERVICE of (1) Plaintiff Vertex Pharmaceuticals Incorporated's Second Supplemental Initial Infringement Contentions, (2) Plaintiff Vertex Pharmaceuticals Incorporated's Second Supplemental Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Interrogatories (Nos. 1, 2, 3, 7, 8 and 9), and (3) Plaintiff Vertex Pharmaceuticals Incorporated's Third Amended Initial Disclosures Under Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 02/28/2025) (3) |
| Feb 19, 2025 | 128 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Supplemental Initial Infringement Contentions - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 02/19/2025) (3) |
| Feb 12, 2025 | 126 | NOTICE to Take Deposition of Morgan Savage on February 14, 2025, at 8:30 AM filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 2/12/2025 (nms). (Entered: 02/12/2025) (0) |
| Feb 12, 2025 | 127 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Supplemental Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Interrogatories (Nos. 1, 2, 3, 4, 6, and 7) filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 02/12/2025) (3) |
| Jan 30, 2025 | 124 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's Third Set of Interrogatories (NOS.22-23), filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 1/30/2025 (nms). (Entered: 01/30/2025) (0) |
| Jan 30, 2025 | 125 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's Third Set of Requests for Production (NO. 126), filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 1/30/2025 (nms). (Entered: 01/30/2025) (0) |
| Jan 17, 2025 | 122 | MOTION for Pro Hac Vice Appearance of Attorney Kevin Georgek and Samantha J. Kokonis - filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) (Entered: 01/17/2025) (5) |
| Jan 17, 2025 | 123 | Pro Hac Vice Fee - Credit Card Payment received for Kevin Georgek and Samantha J. Kokonis. ( re 122 MOTION for Pro Hac Vice Appearance of Attorney Kevin Georgek and Samantha J. Kokonis )( Payment of $ 100, receipt number ADEDC-4593444).(Fahnestock, Derek) (Entered: 01/17/2025) (0) |
| Jan 15, 2025 | 119 | Joint Stipulation and [Proposed] Order to Amend Scheduling Order, by Lupin Pharmaceuticals, Inc., Lupin Limited. (Murphy, Francis) Modified on 1/15/2025 (nms). (Entered: 01/15/2025) (2) |
| Jan 15, 2025 | 120 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's Second Set of Interrogatories (NOS. 7-21), filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 1/16/2025 (nms). (Entered: 01/15/2025) (0) |
| Jan 15, 2025 | 121 | NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiff Vertex Pharmaceutical Incorporated's First Set of Requests for Admission (NOS. 1-33), filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 1/16/2025 (nms). (Entered: 01/15/2025) (0) |
| Jan 14, 2025 | 118 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Supplemental Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's First Set of Interrogatories (Nos. 1-6), filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 1/15/2025 (nms). (Entered: 01/14/2025) (0) |
| Jan 13, 2025 | 117 | NOTICE OF SERVICE of Vertex Pharmaceuticals Incorporated's Responses and Objections to Defendants' Notice of Deposition to Vertex Pursuant to Federal Rule of Civil Procedure 30(b)(6) - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 01/13/2025) (3) |
| Jan 9, 2025 | 116 | REDACTED VERSION of 113 Sealed Notice to Take Deposition, by Lupin Pharmaceuticals, Inc., Lupin Limited. (Murphy, Francis) Modified on 1/9/2025 (nms). (Entered: 01/09/2025) (12) |
| Jan 2, 2025 | 115 | NOTICE of Change of Firm Affiliation of Certain Pro Hac Vice Counsel by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 1/2/2025 (nms). (Entered: 01/02/2025) (0) |
| Dec 31, 2024 | 114 | NOTICE OF SERVICE of (1) Plaintiff Vertex Pharmaceuticals Incorporated's Third Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. (No. 126) and (2) Plaintiff Vertex Pharmaceuticals Incorporated's Third Set of Interrogatories to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. (Nos. 22-23) - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 12/31/2024) (3) |
| Dec 20, 2024 | 108 | NOTICE to Take Deposition of Eleni Dokou on January 20, 2025, filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 12/20/2024 (nms). (Entered: 12/20/2024) (0) |
| Dec 20, 2024 | 109 | NOTICE to Take Deposition of Hayden Thomas on January 17, 2025, filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 12/20/2024 (nms). (Entered: 12/20/2024) (0) |
| Dec 20, 2024 | 110 | NOTICE to Take Deposition of Kirk Overhoff, filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 12/20/2024 (nms). (Entered: 12/20/2024) (0) |
| Dec 20, 2024 | 111 | NOTICE to Take Deposition of Mark Strohmeier on January 28, 2025, filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 12/20/2024 (nms). (Entered: 12/20/2024) (0) |
| Dec 20, 2024 | 112 | NOTICE to Take Deposition of Meghna Jai Israni on January 13, 2025, filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 12/20/2024 (nms). (Entered: 12/20/2024) (0) |
| Dec 20, 2024 | 113 | [SEALED] NOTICE to Take Deposition of Vertex Pursuant to FED. R. CIV P. 30(b)(6) on January 15, 2025, filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Murphy, Francis) Modified on 12/20/2024 (nms). (Entered: 12/20/2024) (0) |
| Dec 16, 2024 | 107 | NOTICE OF SERVICE of (1) Plaintiff Vertex Pharmaceuticals Incorporated's First Set of Requests for Admission to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. (Nos. 1-33) and (2) Plaintiff Vertex Pharmaceuticals Incorporated's Second Set of Interrogatories to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. (Nos. 7-21) - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 12/16/2024) (3) |
| Dec 10, 2024 | 106 | CLAIM CONSTRUCTION ORDER. Signed by Judge Richard G. Andrews on 12/10/2024. (nms) (Entered: 12/10/2024) (2) |
| Dec 9, 2024 | 104 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Vertex Pharmaceuticals Incorporated's Notice of Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. Pursuant to FED. R. CIV. P. 30(b)(6), filed by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Certificate of Service )(Murphy, Francis) Modified on 12/10/2024 (nms). (Entered: 12/09/2024) (0) |
| Dec 9, 2024 | 105 | PROPOSED Claim Construction Order, by Vertex Pharmaceuticals Incorporated. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 12/9/2024 (nms). (Entered: 12/09/2024) (0) |
| Dec 6, 2024 | 103 | Official Transcript of Markman Hearing held on 11/20/24 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/27/2024. Redacted Transcript Deadline set for 1/6/2025. Release of Transcript Restriction set for 3/6/2025. (Triozzi, Heather) (Entered: 12/06/2024) (34) |
| Dec 5, 2024 | 102 | REDACTED VERSION of 100 Notice to Take Deposition - by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) (Entered: 12/05/2024) (6) |
| Dec 4, 2024 | 101 | MEMORANDUM OPINION providing claim construction for term in U.S. Patent No. 11,752,106. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion (see Memorandum Opinion for further details). Signed by Judge Richard G. Andrews on 12/4/2024. (aas) (Entered: 12/04/2024) (11) |
| Nov 21, 2024 | 90 | NOTICE to Take Deposition of Elati Ravi Ram Chandrashekar on December 10, 2024 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 91 | NOTICE to Take Deposition of Vishal Ahire on December 12, 2024 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 92 | NOTICE to Take Deposition of Dhanashree Mistry on December 17, 2024 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 93 | NOTICE to Take Deposition of Nandkumar Bhilare on December 19, 2024 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 94 | NOTICE to Take Deposition of Anurag Trivedi on January 7, 2025 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 95 | NOTICE to Take Deposition of Pramod Dahibhate on January 9, 2025 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 96 | NOTICE to Take Deposition of Pritesh Upadhyay on January 14, 2025 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 97 | NOTICE to Take Deposition of Subhash Gore on January 16, 2025 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 98 | NOTICE to Take Deposition of Upkar Bhardwaj on January 21, 2025 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 99 | NOTICE to Take Deposition of Jason Gensburger on January 23, 2025 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (3) |
| Nov 21, 2024 | 100 | [SEALED] NOTICE to Take Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. on December 10, 2024 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/21/2024) (0) |
| Nov 5, 2024 | 89 | ORAL ORDER: Due to a scheduling conflict the Markman Hearing set for 11/20/2024, will now start at 3:00 PM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 11/5/2024. (nms) (Entered: 11/05/2024) (0) |
| Oct 31, 2024 | 88 | ORAL ORDER: The Joint Motion Requesting Claim Construction (D.I. 87 ) is GRANTED. Each side will be limited to 20 minutes. Ordered by Judge Richard G. Andrews on 10/31/2024. (nms) (Entered: 10/31/2024) (0) |
| Oct 30, 2024 | 85 | JOINT Claim Construction Brief, filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 10/31/2024 (nms). (Entered: 10/30/2024) (30) |
| Oct 30, 2024 | 86 | Joint Appendix to 85 Joint Claim Construction Brief, by Vertex Pharmaceuticals Incorporated. (Attachments: # 1 Exhibits A-I, # 2 Exhibit J)(Fahnestock, Derek) Modified on 10/31/2024 (nms). (Entered: 10/30/2024) (0) |
| Oct 30, 2024 | 87 | Joint Motion Requesting Claim Construction - filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 10/31/2024 (nms). (Entered: 10/30/2024) (2) |
| Oct 25, 2024 | 84 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Sur-Reply Claim Construction Brief with respect to the '106 Patent, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 10/29/2024 (nms). (Entered: 10/25/2024) (0) |
| Oct 11, 2024 | 83 | NOTICE OF SERVICE of Plaintiff's Reply Claim Construction Brief - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 10/11/2024) (3) |
| Oct 10, 2024 | 82 | SO ORDERED Granting 81 Joint Stipulation to Amend Scheduling Order (*Reset Deadlines: Fact Discovery completed by 1/31/2025, Opening Expert Reports due by 2/28/2025, Rebuttal Expert Reports due by 4/18/2025) (see Order for further details). Signed by Judge Richard G. Andrews on 10/10/2024. (nms) (Entered: 10/10/2024) (2) |
| Oct 9, 2024 | 81 | Joint Stipulation to Amend Scheduling Order, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 10/10/2024 (nms). (Entered: 10/09/2024) (2) |
| Sep 20, 2024 | 80 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc's Responsive Claim Construction Brief with Respect to the '106 Patent, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 9/23/2024 (nms). (Entered: 09/20/2024) (0) |
| Aug 30, 2024 | 79 | NOTICE OF SERVICE of Plaintiff's Opening Claim Construction Brief filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 08/30/2024) (3) |
| Aug 9, 2024 | 78 | JOINT Claim Construction Chart, by Vertex Pharmaceuticals Incorporated. (Attachments: # 1 Exhibit A)(Fahnestock, Derek) Modified on 8/12/2024 (nms). (Entered: 08/09/2024) (0) |
| Jul 26, 2024 | 76 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc's Disclosure of Claim Terms and Preliminary Construction with Respect to the '106 Patent filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) (Entered: 07/26/2024) (2) |
| Jul 26, 2024 | 77 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Proposed Claim Terms for Construction With Respect to U.S. Patent No. 11,752,106 - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 07/26/2024) (3) |
| Jul 12, 2024 | 75 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Invalidity Contentions with Respect to US Patent No. 11,752,106 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) (Entered: 07/12/2024) (2) |
| Jun 28, 2024 | 74 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Initial Disclosures Under Paragraph 4(c) of the District of Delaware Default Standard for Discovery With Respect to U.S. Patent No. 11,752,106 - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 06/28/2024) (3) |
| Jun 21, 2024 | 73 | ANSWER to 67 Answer to Complaint, Counterclaim (with respect to U.S. Patent No. 11,752,106), by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) Modified on 6/24/2024 (nms). (Entered: 06/21/2024) (15) |
| Jun 7, 2024 | 70 | NOTICE of Lupin Limited and Lupin Pharmaceuticals, Inc's Second Amended initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery by Lupin Limited, Lupin Pharmaceuticals, Inc. (Murphy, Francis) (Entered: 06/07/2024) (2) |
| Jun 7, 2024 | 71 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc's Second Amended Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) (Entered: 06/07/2024) (2) |
| Jun 7, 2024 | 72 | NOTICE OF SERVICE of (1) Plaintiff Vertex Pharmaceuticals Incorporated's Initial Disclosures Under Paragraph 4(a) of the District of Delaware Default Standard for Discovery With Respect to U.S. Patent No. 11,752,106 and (2) Plaintiff Vertex Pharmaceuticals Incorporated's Second Amended Initial Disclosures Under Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 06/07/2024) (3) |
| May 31, 2024 | 67 | ANSWER to Complaint and COUNTERCLAIMS against Vertex Pharmaceuticals Incorporated, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-14, # 2 Certificate of Service)(Murphy, Francis) Modified on 5/31/2024 (nms). (Entered: 05/31/2024) (0) |
| May 31, 2024 | 68 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) (Entered: 05/31/2024) (0) |
| May 31, 2024 | 69 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed, filed by Lupin Limited. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 6/3/2024 (nms). Modified on 6/3/2024 (nms). (Entered: 05/31/2024) (0) |
| May 28, 2024 | 66 | REDACTED VERSION of 64 Letter, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 5/28/2024 (nms). (Entered: 05/28/2024) (1) |
| May 23, 2024 | 63 | Joint Stipulation and [Proposed] Order to Consolidate and Amend Scheduling Order, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 5/23/2024 (nms). (Entered: 05/23/2024) (13) |
| May 23, 2024 | 64 | [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, Joint Stipulation and Proposed Order to Consolidate and Amend Scheduling Order. (Fahnestock, Derek) Modified on 5/23/2024 (nms). (Entered: 05/23/2024) (0) |
| May 23, 2024 | 65 | SO ORDERED Granting Joint Stipulation and Proposed Order to Consolidate and Amend Scheduling Order (D.I. 7 in 24-cv-458-RGA; D.I. 63 in 22-cv-966-RGA) (*Reset Deadlines/Hearings; Amended Pleadings due by 9/16/2024, Fact Discovery completed by 11/22/2024, Joint Claim Construction Brief due by 10/30/2024, Joinder of Parties due by 9/16/2024, A 3-day Bench Trial is set to start 9/15/2025, at 8:30 AM in Courtroom 6A, A Markman Hearing is set for 11/20/2024, at 9:00 AM in Courtroom 6A, A Pretrial Conference is set for 9/5/2025, at 10:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/23/2024. Associated Cases: 1:22-cv-00966-RGA, 1:24-cv-00458-RGA(nms) (Entered: 05/23/2024) (13) |
| Apr 29, 2024 | 61 | MOTION for Pro Hac Vice Appearance of Attorney Alexandra J. Cho - filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) (Entered: 04/29/2024) (4) |
| Apr 29, 2024 | 62 | Pro Hac Vice Fee - Credit Card Payment received for Alexandra J. Cho. ( re 61 MOTION for Pro Hac Vice Appearance of Attorney Alexandra J. Cho )( Payment of $ 50, receipt number ADEDC-4394858).(Fahnestock, Derek) (Entered: 04/29/2024) (0) |
| Apr 11, 2024 | 60 | NOTICE requesting Clerk to remove Mila Owen as co-counsel. Reason for request: no longer with the firm. (Fahnestock, Derek) (Entered: 04/11/2024) (2) |
| Mar 12, 2024 | 59 | Stipulation and Proposed Order for Extension of Time, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) Modified on 3/12/2024 (nms). (Entered: 03/12/2024) (2) |
| Jan 16, 2024 | 58 | NOTICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporated's Second Set of Requests for Production (Nos. 88-125), by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 1/17/2024 (nms). (Entered: 01/16/2024) (0) |
| Dec 15, 2023 | 57 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceuticals Incorporated's Second Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. (Nos. 88-125) - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 12/15/2023) (3) |
| Sep 25, 2023 | 55 | Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding request to removal of remaining claim construction deadlines. (Fahnestock, Derek) Modified on 9/25/2023 (nms). (Entered: 09/25/2023) (1) |
| Sep 25, 2023 | 56 | ORAL ORDER: The request to cancel all remaining claim construction deadlines and hearings (D.I. 55 ) is GRANTED. Ordered by Judge Richard G. Andrews on 9/25/2023. (nms) (Entered: 09/25/2023) (0) |
| Sep 8, 2023 | 53 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Disclosure of Claim Terms and Preliminary Construction with Respect to the "916 Patent filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Parshall, Jonathan) (Entered: 09/08/2023) (2) |
| Sep 8, 2023 | 54 | NOTICE OF SERVICE of Identification of Claim Terms and Proposed Constructions filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 09/08/2023) (3) |
| Aug 25, 2023 | 52 | NOTICE of Service of Lupin Ltd and Lupin Pharmaceuticals, Inc's Initial Invalidity Contentions with Respect to U.s. Patent No. 11,564,916, filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Parshall, Jonathan) Modified on 8/26/2023 (nms). (Entered: 08/25/2023) (2) |
| Aug 11, 2023 | 51 | NOTICE OF SERVICE of Initial Disclosures Under Paragraph 4(a) of the District of Delaware Default Standard for Discovery with Respect to U.S. Patent No. 11,564,916 filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 08/11/2023) (3) |
| Aug 4, 2023 | 50 | ANSWER to 44 Answer to Complaint, Counterclaim - by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 08/04/2023) (17) |
| Jul 21, 2023 | 48 | NOTICE OF SERVICE of (1) Initial Disclosures Under Paragraph 4(a) of the District of Delaware Default Standard for Discovery with Respect to U.S. Patent No. 11,564,916; and (2) Amended Initial Disclosures Under Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 07/21/2023) (3) |
| Jul 21, 2023 | 49 | NOTICE OF SERVICE of (1) Defendants Lupin Ltd., and Lupin Pharmaceuticals, Inc.s First Amended Initial Disclosures Pursuant to Paragraph 3 of The Delaware Default Standard for Discovery; and (2) Defendants Lupin Ltd., and Lupin Pharmaceuticals, Inc.s First Amended Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Murphy, Francis) Modified on 7/24/2023 (nms). (Entered: 07/21/2023) (0) |
| Jul 18, 2023 | 47 | REDACTED VERSION of 42 Letter, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 7/19/2023 (nms). (Entered: 07/18/2023) (2) |
| Jul 14, 2023 | 44 | ANSWER to 1 Complaint, and COUNTERCLAIM against Vertex Pharmaceuticals Incorporated, by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Exhibits 1-12)(Murphy, Francis) Modified on 7/14/2023 (nms). (Entered: 07/14/2023) (0) |
| Jul 14, 2023 | 45 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited. (Murphy, Francis) (Entered: 07/14/2023) (2) |
| Jul 14, 2023 | 46 | Disclosure Statement pursuant to Rule 7.1: identifying filed by Lupin Pharmaceuticals, Inc.. (Murphy, Francis) (Entered: 07/14/2023) (2) |
| Jul 10, 2023 | 43 | SO ORDERED Granting (D.I. 41 in 22-cv-966-RGA; D.I. 7 in 23-cv-583-RGA) Joint Stipulation and Proposed Order to Consolidate and Amend Scheduling Order. These actions are consolidated for all purposes and all filings shall be made in 22cv966-RGA, only (*Reset Deadlines/Hearings: Amended Pleadings due by 10/27/2023, Fact Discovery completed by 6/28/2024, Joint Claim Construction Brief due by 12/18/2023, Joinder of Parties due by 10/27/2023, a three day Bench Trial is set to start 4/14/2025, at 8:30 AM in Courtroom 6A, A Markman Hearing is set for 1/18/2024, at 9:00 AM in Courtroom 6A, a Pretrial Conference is set for 4/4/2025, at 2:00 PM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 7/10/2023. Associated Cases: 1:22-cv-00966-RGA, 1:23-cv-00583-RGA(nms) (Entered: 07/10/2023) (11) |
| Jul 7, 2023 | 41 | Joint Stipulation and [Proposed] Order to Consolidate and Amend Scheduling Order, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 7/10/2023 (nms). (Entered: 07/07/2023) (13) |
| Jul 7, 2023 | 42 | [SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding proposed consolidated scheduling order. (Fahnestock, Derek) Modified on 7/10/2023 (nms). (Entered: 07/07/2023) (0) |
| Apr 26, 2023 | 40 | NOTICE OF SERVICE of (1) Plaintiff Vertex Pharmaceutical Incorporated's Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-111) and (2) Plaintiff Vertex Pharmaceuticals Incorporated's Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Interrogatories (Nos. 1-10) - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 04/26/2023) (3) |
| Mar 31, 2023 | 39 | ORAL ORDER: The request to cancel the Markman hearing (D.I. 38 ) is GRANTED. Ordered by Judge Richard G. Andrews on 3/31/2023. (nms) (Entered: 03/31/2023) (0) |
| Mar 30, 2023 | 38 | Joint Letter to The Honorable Richard G. Andrews, regarding claim construction deadlines. (Fahnestock, Derek) Modified on 3/31/2023 (nms). (Entered: 03/30/2023) (1) |
| Mar 27, 2023 | 36 | NOTICE OF SERVICE regarding The undersigned hereby certifies that a copy of Defendants Lupin Ltd., and Lupin Pharmaceuticals, Inc.s First Set of Requests for Production of Documents and Things to Vertex Pharmaceuticals Inc. (NOS. 1-111) was caused to be served on March 27, 2023, upon the following via electronic mail: filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Parshall, Jonathan) Modified on 3/28/2023 (nms). (Entered: 03/27/2023) (2) |
| Mar 27, 2023 | 37 | NOTICE OF SERVICE of Notice of Service The undersigned hereby certifies that a copy of Defendants Lupin Ltd., and Lupin Pharmaceuticals, Inc.s First Set of Interrogatories to Vertex Pharmaceuticals Inc. (NOS. 1-10) was caused to be served on March 27, 2023, upon the following via electronic mail: filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Parshall, Jonathan) (Entered: 03/27/2023) (2) |
| Mar 17, 2023 | 35 | NOTICE requesting Clerk to remove Laura Logsdon as co-counsel. Reason for request: no longer with the firm. (Fahnestock, Derek) (Entered: 03/17/2023) (2) |
| Mar 16, 2023 | 33 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Preliminary Disclosure of Claim Terms for Construction was caused to be served on March 16, 2023 via electronic mail filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Parshall, Jonathan) (Entered: 03/16/2023) (2) |
| Mar 16, 2023 | 34 | NOTICE OF SERVICE of Plaintiff's Identification of Claim Terms for Construction - filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 03/16/2023) (3) |
| Mar 2, 2023 | 32 | NOTICE of Invalidity Contentions with respect to U.S. Patent Nos. 8,883,206, 10,272,046, 10,646,481 and 11,147,770, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) Modified on 3/6/2023 (nms). (Entered: 03/02/2023) (2) |
| Feb 27, 2023 | 30 | ORAL ORDER: Due to a scheduling conflict the Pretrial Conference set for 9/6/2024, is CANCELED. The Pretrial Conference is now rescheduled for 9/4/2024, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 2/27/2023. (nms) (Entered: 02/27/2023) (0) |
| Feb 27, 2023 | 31 | NOTICE OF SERVICE of Defendants Lupin Ltd., and Lupin Pharmaceuticals, Inc.s Objections and Responses to Plaintiff Vertex Pharmaceuticals Incorporateds First Set of Requests for Production (NOS. 1-87) and Objections filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) (Entered: 02/27/2023) (2) |
| Jan 24, 2023 | 29 | NOTICE OF SERVICE of Plaintiff Vertex Pharmaceutical Incorporated's Initial Disclosures Under Paragraph 4(c) of the District of Delaware Default Standard for Discovery filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 01/24/2023) (3) |
| Nov 16, 2022 | 27 | NOTICE of Defendants Lupin Ltd., and Lupin Pharmaceuticals, Inc.s Rule 26(a)(1) Initial Disclosures by Lupin Limited, Lupin Pharmaceuticals, Inc. (Parshall, Jonathan) (Entered: 11/16/2022) (2) |
| Nov 16, 2022 | 28 | NOTICE OF SERVICE of (1) Plaintiff Vertex Pharmaceuticals Incorporated's Initial Disclosures Under Federal Rule of Civil Procedure 26(A)(1) and Paragraph 3 of the Delaware Default Standard for Discovery and (2) Plaintiff Vertex Pharmaceuticals Incorporated's Initial Disclosures Under Paragraph 4(A) of the District Of Delaware Default Standard for Discovery filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 11/16/2022) (3) |
| Nov 14, 2022 | 26 | SO ORDERED Granting 25 Stipulated Protective Order. Signed by Judge Richard G. Andrews on 11/14/2022. (nms) (Entered: 11/14/2022) (28) |
| Nov 11, 2022 | 25 | PROPOSED Stipulated Protective Order, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 11/14/2022 (nms). (Entered: 11/11/2022) (28) |
| Nov 10, 2022 | 24 | MOTION for Pro Hac Vice Appearance of Attorney Jacob C. Britz & Amy Lange - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) (Entered: 11/10/2022) (4) |
| Oct 27, 2022 | 22 | STIPULATION TO EXTEND TIME for the parties to submit a protective order to November 11, 2022 - filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) (Entered: 10/27/2022) (1) |
| Oct 27, 2022 | 23 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr; James Peterka; Nina Vachhani - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) (Entered: 10/27/2022) (5) |
| Oct 14, 2022 | 19 | Letter to The Honorable Richard G. Andrews from Derek J. Fahnestock regarding dial-in information for the Rule 16 teleconference scheduled for Monday, October 17 at 2:00 p.m.. (Fahnestock, Derek) (Entered: 10/14/2022) (1) |
| Oct 14, 2022 | 20 | SCHEDULING ORDER: Joinder of Parties due by 3/31/2023. Amended Pleadings due by 3/31/2023. Fact Discovery completed by 11/17/2023. Joint Claim Construction Brief due by 6/15/2023. A Markman Hearing is set for 8/28/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 9/6/2024, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 9/16/2024, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 10/14/2022. (nms) (Entered: 10/14/2022) (10) |
| Oct 14, 2022 | 21 | ORAL ORDER: The Rule 16(b) Conference scheduled for 10/17/2022, is CANCELED. Ordered by Judge Richard G. Andrews on 10/14/2022. (nms) (Entered: 10/14/2022) (0) |
| Oct 13, 2022 | 18 | PROPOSED Scheduling Order, by Vertex Pharmaceuticals Incorporated. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 10/13/2022 (nms). (Entered: 10/13/2022) (Main Document) (12) |
| Oct 13, 2022 | 18 | PROPOSED Scheduling Order, by Vertex Pharmaceuticals Incorporated. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 10/13/2022 (nms). (Entered: 10/13/2022) (Letter to The Honorable Richard G. Andrews) (1) |
| Oct 7, 2022 | 17 | ANSWER to 12 Answer to Complaint, Counterclaim by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 10/07/2022) (12) |
| Sep 27, 2022 | 16 | Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 10/17/2022, at 2:00 PM (see Order for further details). Signed by Judge Richard G. Andrews on 9/27/2022. (nms) (Entered: 09/27/2022) (1) |
| Sep 26, 2022 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, Alison Hanstead, Joel L. Broussard, C. Sebastian Zonte, Mila Owen and Laura Logsdon - filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) (Entered: 09/26/2022) (9) |
| Sep 16, 2022 | 12 | ANSWER to 1 Complaint, and COUNTERCLAIMS against All Plaintiffs, by Lupin Limited, Lupin Pharmaceuticals, Inc..(Murphy, Francis) Modified on 9/17/2022 (nms). (Entered: 09/16/2022) (30) |
| Sep 16, 2022 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) (Entered: 09/16/2022) (2) |
| Sep 16, 2022 | 14 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Murphy, Francis) (Entered: 09/16/2022) (2) |
| Aug 17, 2022 | 11 | STIPULATION for Extension of Time - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Parshall, Jonathan) Modified on 8/17/2022 (nms). (Entered: 08/17/2022) (2) |
| Aug 15, 2022 | 9 | NOTICE of Appearance by Jonathan L. Parshall on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Parshall, Jonathan) (Entered: 08/15/2022) (1) |
| Aug 15, 2022 | 10 | NOTICE of Appearance by Francis J. Murphy, Jr on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Murphy, Francis) (Entered: 08/15/2022) (1) |
| Aug 1, 2022 | 8 | Declaration (10) Docket Text: DECLARATION of Mailing, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 8/1/2022 (nms). |
| Jul 27, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 27, 2022 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vertex Pharmaceuticals Incorporated. Lupin Pharmaceuticals, Inc. served on 7/27/2022, answer due 8/17/2022. (Blumenfeld, Jack) |
| Jul 22, 2022 | 1 | Main Document (14) Docket Text: COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-3921217.) - filed by Vertex Pharmaceuticals Incorporated. (Attachments: # (1) Exhibit A-C, # (2) Exhibit D, # (3) Civil Cover Sheet)(mpb) |
| Jul 22, 2022 | 1 | Exhibit A-C (257) |
| Jul 22, 2022 | 1 | Exhibit D (111) |
| Jul 22, 2022 | 1 | Civil Cover Sheet (1) |
| Jul 22, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Jul 22, 2022 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,883,206 B2 ;10,272,046 B2 ;10,646,481 B2 ;11,147,770 B2. (mpb) |
| Jul 22, 2022 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/10/2022. Date of Expiration of Patent: 2/27/2033 and 8/13/2029.Thirty Month Stay Deadline: 12/10/2024. (mpb) |
| Jul 22, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Vertex Pharmaceuticals Incorporated. (mpb) |
| Jul 22, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to Lupin Limited on 7/22/2022; Lupin Pharmaceuticals, Inc. on 7/22/2022. (Attachments: # (1) Summons)(mpb) |
| Jul 22, 2022 | 6 | Summons (2) |
| Jul 22, 2022 | 1 | Complaint* (1) |
